The global BCG Vaccine market size was US$ 80.4 million in 2024 and is forecast to a readjusted size of US$ 99 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Market Drivers for BCG Vaccine:
High Prevalence of Tuberculosis (TB): The increasing incidence of TB, especially in densely populated and low-income countries, drives the demand for BCG vaccines to prevent the disease, particularly among children and healthcare workers.
Rising Awareness and Immunization Programs: Many governments and health organizations promote vaccination to control TB outbreaks, providing funding and infrastructure to distribute BCG vaccines widely, particularly in high-risk regions.
Growing Healthcare Investments in Emerging Markets: Expanding healthcare infrastructure and government spending in emerging economies have increased the availability and accessibility of the BCG vaccine.
Development of New TB Strains: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains has highlighted the need for effective preventative measures like the BCG vaccine.
Market Challenges for BCG Vaccine:
Limited Efficacy in Adults: The BCG vaccine’s effectiveness diminishes in adults, as it primarily prevents severe forms of TB in children rather than pulmonary TB, which is common in adults.
Side Effects and Safety Concerns: For individuals with weakened immune systems, the live BCG vaccine may pose health risks, which restricts its use among certain populations.
Supply Chain Constraints: Manufacturing challenges and periodic shortages impact the availability of BCG vaccines in some regions, particularly low-income countries.
Competition from New Vaccines and Treatments: Research on new TB vaccines and alternative treatments could reduce the reliance on BCG, especially if future solutions offer broader protection across age groups.
The global BCG Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô
Taj Pharmaceuticals
Ataulpho de Paiva
±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ
Queen Saovabha Mem. Inst
Microgen
By Type: (Dominant Segment vs High-Margin Innovation)
Immune Vaccine
Therapy Vaccine
By Application: (Core Demand Driver vs Emerging Opportunity)
Self-Procurement
UNICEF
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Merck in Europe)
- Emerging Product Trends: Immune Vaccine adoption vs. Therapy Vaccine premiumization
- Demand-Side Dynamics: Self-Procurement growth in China vs. UNICEF potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of BCG Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapy Vaccine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., UNICEF in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Immune Vaccine dominance in Europe vs. Therapy Vaccine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 BCG Vaccine Product Scope
1.2 BCG Vaccine by Type
1.2.1 Global BCG Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 BCG Vaccine by Application
1.3.1 Global BCG Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global BCG Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global BCG Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global BCG Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global BCG Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global BCG Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global BCG Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global BCG Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global BCG Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global BCG Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global BCG Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global BCG Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America BCG Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe BCG Vaccine Market Size and Prospective (2020-2031)
2.4.3 China BCG Vaccine Market Size and Prospective (2020-2031)
2.4.4 Japan BCG Vaccine Market Size and Prospective (2020-2031)
2.4.5 India BCG Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global BCG Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global BCG Vaccine Sales by Type (2020-2025)
3.1.2 Global BCG Vaccine Revenue by Type (2020-2025)
3.1.3 Global BCG Vaccine Price by Type (2020-2025)
3.2 Global BCG Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global BCG Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global BCG Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global BCG Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types BCG Vaccine Representative Players
4 Global Market Size by Application
4.1 Global BCG Vaccine Historic Market Review by Application (2020-2025)
4.1.1 Global BCG Vaccine Sales by Application (2020-2025)
4.1.2 Global BCG Vaccine Revenue by Application (2020-2025)
4.1.3 Global BCG Vaccine Price by Application (2020-2025)
4.2 Global BCG Vaccine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global BCG Vaccine Sales Forecast by Application (2026-2031)
4.2.2 Global BCG Vaccine Revenue Forecast by Application (2026-2031)
4.2.3 Global BCG Vaccine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in BCG Vaccine Application
5 Competition Landscape by Players
5.1 Global BCG Vaccine Sales by Players (2020-2025)
5.2 Global Top BCG Vaccine Players by Revenue (2020-2025)
5.3 Global BCG Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine as of 2024)
5.4 Global BCG Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of BCG Vaccine, Product Type & Application
5.7 Global Key Manufacturers of BCG Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America BCG Vaccine Sales by Company
6.1.1.1 North America BCG Vaccine Sales by Company (2020-2025)
6.1.1.2 North America BCG Vaccine Revenue by Company (2020-2025)
6.1.2 North America BCG Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America BCG Vaccine Sales Breakdown by Application (2020-2025)
6.1.4 North America BCG Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe BCG Vaccine Sales by Company
6.2.1.1 Europe BCG Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe BCG Vaccine Revenue by Company (2020-2025)
6.2.2 Europe BCG Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe BCG Vaccine Sales Breakdown by Application (2020-2025)
6.2.4 Europe BCG Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China BCG Vaccine Sales by Company
6.3.1.1 China BCG Vaccine Sales by Company (2020-2025)
6.3.1.2 China BCG Vaccine Revenue by Company (2020-2025)
6.3.2 China BCG Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China BCG Vaccine Sales Breakdown by Application (2020-2025)
6.3.4 China BCG Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan BCG Vaccine Sales by Company
6.4.1.1 Japan BCG Vaccine Sales by Company (2020-2025)
6.4.1.2 Japan BCG Vaccine Revenue by Company (2020-2025)
6.4.2 Japan BCG Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 Japan BCG Vaccine Sales Breakdown by Application (2020-2025)
6.4.4 Japan BCG Vaccine Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India BCG Vaccine Sales by Company
6.5.1.1 India BCG Vaccine Sales by Company (2020-2025)
6.5.1.2 India BCG Vaccine Revenue by Company (2020-2025)
6.5.2 India BCG Vaccine Sales Breakdown by Type (2020-2025)
6.5.3 India BCG Vaccine Sales Breakdown by Application (2020-2025)
6.5.4 India BCG Vaccine Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Business Overview
7.1.3 Merck BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Merck BCG Vaccine Products Offered
7.1.5 Merck Recent Development
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Company Information
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Japan BCG Lab BCG Vaccine Products Offered
7.2.5 Japan BCG Lab Recent Development
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Information
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Serum Institute of India BCG Vaccine Products Offered
7.3.5 Serum Institute of India Recent Development
7.4 AJ Vaccines
7.4.1 AJ Vaccines Company Information
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 AJ Vaccines BCG Vaccine Products Offered
7.4.5 AJ Vaccines Recent Development
7.5 BioFarma
7.5.1 BioFarma Company Information
7.5.2 BioFarma Business Overview
7.5.3 BioFarma BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 BioFarma BCG Vaccine Products Offered
7.5.5 BioFarma Recent Development
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Company Information
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 GreenSignal Bio Pharma BCG Vaccine Products Offered
7.6.5 GreenSignal Bio Pharma Recent Development
7.7 China National Biotec
7.7.1 China National Biotec Company Information
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 China National Biotec BCG Vaccine Products Offered
7.7.5 China National Biotec Recent Development
7.8 µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô
7.8.1 µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô Company Information
7.8.2 µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô Business Overview
7.8.3 µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô BCG Vaccine Products Offered
7.8.5 µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô Recent Development
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Company Information
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Taj Pharmaceuticals BCG Vaccine Products Offered
7.9.5 Taj Pharmaceuticals Recent Development
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Company Information
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Ataulpho de Paiva BCG Vaccine Products Offered
7.10.5 Ataulpho de Paiva Recent Development
7.11 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ
7.11.1 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ Company Information
7.11.2 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ Business Overview
7.11.3 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.11.4 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ BCG Vaccine Products Offered
7.11.5 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ Recent Development
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Company Information
7.12.2 Queen Saovabha Mem. Inst Business Overview
7.12.3 Queen Saovabha Mem. Inst BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Queen Saovabha Mem. Inst BCG Vaccine Products Offered
7.12.5 Queen Saovabha Mem. Inst Recent Development
7.13 Microgen
7.13.1 Microgen Company Information
7.13.2 Microgen Business Overview
7.13.3 Microgen BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Microgen BCG Vaccine Products Offered
7.13.5 Microgen Recent Development
8 BCG Vaccine Manufacturing Cost Analysis
8.1 BCG Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of BCG Vaccine
8.4 BCG Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 BCG Vaccine Distributors List
9.3 BCG Vaccine Customers
10 BCG Vaccine Market Dynamics
10.1 BCG Vaccine Industry Trends
10.2 BCG Vaccine Market Drivers
10.3 BCG Vaccine Market Challenges
10.4 BCG Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
µþ¾±´Ç³¾±ð»åÌý³¢³Ü²ú±ô¾±²Ô
Taj Pharmaceuticals
Ataulpho de Paiva
±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ
Queen Saovabha Mem. Inst
Microgen
Ìý
Ìý
*If Applicable.